regenicin header

Regenicin CEO to Speak at Proactive Investor Conference, 11/18/2010 in New York, NY November 18th, 2010

regenicin news release

Regenicin CEO to Speak at Proactive Investor Conference, New York, NY

NEW YORK, Nov. 18, 2010 /PRNewswire/ -- Regenicin, Inc. (OTC Bulletin Board: RGIN) a biotechnology company specializing in the development of regenerative cell therapies to restore the health of damaged tissues and organs, will be represented by company CEO, Randall McCoy at the Proactive Investor Conference today at the Intercontinental New York Barclay Hotel.

Mr. McCoy will present Regenicin's core concept and business model for bringing regenerative medicine products to market. Regenicin will be among five public biotechnology and medical technology companies that will be presenting to institutional and private investors.

return to 2010 Press and News Releases
return to Home Page

About Regenicin
Regenicin, Inc. (OTC Bulletin Board: RGIN), is a biotechnology company specializing in the development of regenerative cell therapies to restore the health of damaged tissues and organs. Regenicin, which was founded in 2010, has assembled a world-class management team with a proven track record for developing and bringing innovative medical devices and biotechnology products to market. The company is publicly traded with headquarters in New Jersey.

Safe Harbor Statement.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURC:E Regenicin, Inc.